SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-23-061169
Filing Date
2023-05-16
Accepted
2023-05-16 07:10:02
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2315611-1_424b5.htm 424B5 472728
2 GRAPHIC lg_outlooktherapeutics-4c.jpg GRAPHIC 50768
  Complete submission text file 0001104659-23-061169.txt   543918
Mailing Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830
Business Address 485 ROUTE 1 SOUTH BUILDING F, SUITE 320 ISELIN NJ 08830 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 424B5 | Act: 33 | File No.: 333-254778 | Film No.: 23925558
SIC: 2836 Biological Products, (No Diagnostic Substances)